Psychological effects of personalized dementia risk disclosure: The Barcelonaβeta Dementia Prevention Research Clinic study
Abstract Background Approximately 35‐40% of new patients at memory clinics are cognitively intact individuals concerned about their dementia risk. The demand for personalized risk profiling and preventive strategies for those at higher dementia risk is in need of innovative infrastructures. However, disclosing dementia risk estimates raises concerns about potential negative emotional impacts. To address this challenge, the Barcelonaβeta Dementia Prevention Research Clinic, was established to evaluate the risks and benefits of novel prevention infrastructures and the potential impact of dementia risk disclosure. Here we focus on the psychological effects of personalized dementia risk disclosure on cognitively unimpaired individuals with subjective cognitive decline (SCD). Method Participants aged 60‐80 with cognitive complaints were pre‐selected using web‐based algorithms. Eligible participants were invited to an in‐person visit and a clinical diagnosis was established after neuropsychological, blood tests and magnetic resonance imaging assessments. Dementia risk over 5 years (%risk) was calculated and disclosed with personalized prevention plans. Impact on depression (CES‐D), anxiety (STAI), and test‐related distress (IGT‐AD) was assessed up to 12 months post‐disclosure. SCD participants were categorized into “high dementia risk” (HDR, %risk>10.8) and “low dementia risk” (LDR, %risk<3.6) groups, based on previous epidemiological evidence. Wilcoxon rank‐sum tests and Spearman’s rank correlation analyzed between‐group differences and correlations at different time points. Result The percentage of 5‐years dementia risk was disclosed to 192 participants with SCD. Test‐related distress (IGT‐AD) was consistently higher in HDR (N = 25) vs. LDR (N = 55), while CES‐D and STAI showed no significant differences between groups (Table 1, Figure 1). Similar results were observed in correlation analyses for the entire sample (Table 2). Median CES‐D and STAI‐S values remained below clinically relevant cutoffs for depression and anxiety across all visits. Conclusion Disclosure of dementia risk heightened test‐related distress but did not manifest clinically relevant negative effects in anxiety and depression scales. The potential impact of this psychological response on promoting engagement in preventive behaviors warrants further exploration.
Authors
- Karine Fauria (ORCID: https://orcid.org/0000-0003-1506-4405)
- Gonzalo Sánchez‐Benavides (ORCID: https://orcid.org/0000-0003-3454-800X)
- José Luís Molinuevo (ORCID: https://orcid.org/0000-0003-0485-6001)
- Juan Domingo Gispert (ORCID: https://orcid.org/0000-0002-6155-0642)
- Oriol Grau‐Rivera (ORCID: https://orcid.org/0000-0002-4730-5341)
- Marc Suárez‐Calvet (ORCID: https://orcid.org/0000-0002-2993-569X)
- Carolina Minguillón (ORCID: https://orcid.org/0000-0002-2782-6908)
Institutions
- Lundbeck (Denmark) (DK)
- Instituto de Salud Carlos III (ES)
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
- Pasqual Maragall Foundation (ES)
- Barcelonaβeta Brain Research Center (ES)
- Hospital Del Mar (ES)
- Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (ES)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.092351
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00